Completed PHASE2 INTERVENTIONAL 5-arm NCT00454831

Efficacy and Safety of HEP-40 Chitosan for Mild to Moderately Elevated Cholesterol (HEP-40)

A 16 Week With 12 Week Active Treatment Multi-Center, Placebo-Controlled, Randomized Study Evaluating the Efficacy of HEP-40 Chitosan in Managing Moderate Hypercholesterolemia

Sponsor: DNP Canada

Conditions Hypercholesterolemia

Interventions HEP-40 chitosan

Updated 5 times since 2017 Last updated: Nov 14, 2007 Started: Feb 28, 2006 Completion: Sep 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Hypercholesterolemia, this trial is completed. The trial is conducted by DNP Canada and has accumulated 5 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Feb 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

DNP Canada
JSS Medical Research Inc.

Data source: DNP Canada

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Westmount, Canada